---
title: "Fabrazyme(r)"
ocid: "ocds-r6ebe6-0000588661"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000588661"
markdown_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000588661.md"
json_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000588661.json"
source: "Public Contracts Scotland"
current_stage: "Award"
buyer: "THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (\"NSS\")"
published: "2019-09-02"
---

# Fabrazyme(r)

Buyer: THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS")  
Current stage: Award  
OCID: ocds-r6ebe6-0000588661

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000588661)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-r6ebe6-0000588661.json)

## Summary

The procurement process involves the Common Services Agency, also known as NHS National Services Scotland (NSS), which has awarded a contract for the supply of Fabrazyme® (Agalsidase Beta) to Aventis Pharma Ltd Trading As Sanofi. This procurement falls under the health industry category and is located in Edinburgh, UK. The award was made through a limited procurement method without prior publication of a call for competition, and the value of the contract is approximately £7,616,000, signed on 7th August 2019. The procurement is designed to provide essential healthcare supplies to NHS Scotland and is part of a framework agreement comprising an initial period of 21 months with potential extensions.

This tender presents opportunities for large pharmaceutical and healthcare businesses that specialise in manufacturing or distributing critical medical products. Companies involved in the production of biologics or those equipped to meet the patent protection requirements would be particularly well-suited to participate. The process encourages businesses to develop and present their technological capabilities and IP-protected medicinal products, ensuring they can meet the high standards required in the healthcare sector.

## Notice

The supply of Agalsidase Beta 5mg and 35mg Powder for Solution for Infusion to NHS Scotland.

### Lot Information

Lot 1

The supply of Agalsidase Beta 5mg and 35mg Powder for Solution for Infusion to NHS Scotland.

### Procurement Information

Although the patent has expired on Fabrazyme(r) there is no generic competition in the market place due to the difficulties in replicating the manufacturing process.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Public Contracts Scotland |
| Latest notice | https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=SEP365204 |
| Notice type | OJEU - F3 - Contract Award Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Limited |
| Procurement method details | Award procedure without prior publication of a call for competition |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 2 Sep 2019 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 7 Aug 2019 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | £7,316,000 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Complete |
| Awards status | Not specified |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS") |
| Locality | EDINBURGH |
| Post town | Edinburgh |
| Postcode | EH12 9EB |
| Country | Scotland |
| ITL 1 | TLM Scotland |
| ITL 2 | TLM1 East Central Scotland |
| ITL 3 | TLM13 City of Edinburgh |
| Local authority | City of Edinburgh |
| Electoral ward | Drum Brae/Gyle |
| Westminster constituency | Edinburgh South West |
| Delivery location | TLM Scotland |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | AVENTIS PHARMA LTD TRADING AS SANOFI |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 2 Sep 2019 at 00:00 - Award - OJEU - F3 - Contract Award Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=SEP365204
- 17 Jul 2019 at 00:00 - Award - OJEU - F15 - Voluntary Ex Ante Transparency Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUL360892

## Documents

- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUL360892
  Supply of Fabrazyme(r) - The supply of Agalsidase Beta 5mg and 35mg Powder for Solution for Infusion to NHS Scotland.
- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=SEP365204
  Fabrazyme(r) - The supply of Agalsidase Beta 5mg and 35mg Powder for Solution for Infusion to NHS Scotland.

## Notice URLs

- http://
- http://www.nhsscotlandprocurement.scot.nhs.uk/
- https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000588661

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000588661. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-r6ebe6-0000588661.json.